/Merck%20%26%20Co%20Inc%20billboard-by%20monticello%20via%20Shutterstock.jpg)
Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, the company delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.
Shares of this pharmaceutical giant have considerably underperformed the broader market over the past year. MRK has declined 21.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.9%. In 2025, MRK stock is up marginally, compared to the SPX’s 1.9% rise on a YTD basis.